
Arthrosamid for Delaying Surgery in Moderate Knee Osteoarthritis
Arthrosamid offers an effective non-surgical treatment for moderate knee osteoarthritis by cushioning and lubricating the joint to reduce pain and improve mobility. Research demonstrates its safety and lasting benefits up to 24 months, especially in older, non-diabetic patients with less severe OA. Unlike traditional hyaluronic acid injections, Arthrosamid may better delay the need for knee replacement surgery, helping patients maintain active lifestyles and independence. Under expert care from specialists like Professor Paul Lee at MSK Doctors, personalized treatment plans optimize symptom management and quality of life. This promising option supports those seeking alternatives to surgery while maintaining work, hobbies, and daily activities.








